Sign Up to like & get
recommendations!
0
Published in 2020 at "Neuropharmacology"
DOI: 10.1016/j.neuropharm.2019.107845
Abstract: Glibenclamide protects against ischemic injury in both preclinical and clinical studies, presumably by blocking the de novo assembled sulfonylurea receptor 1-transient receptor potential M4 (Sur1-Trpm4) channel induced by ischemia. However, glibenclamide may cause unexpected serious…
read more here.
Keywords:
glibenclamide;
ischemic stroke;
comparable efficacy;
mice ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "British Journal of Dermatology"
DOI: 10.1111/bjd.18327
Abstract: Obesity is associated with psoriasis and negatively affects response to therapy.
read more here.
Keywords:
brodalumab obese;
safety brodalumab;
nonobese patients;
efficacy safety ... See more keywords